← Feed/RSP2024/3011(RSP)Health & Social

Regulation on the market of products containing, consisting of or produced from genetically modified maize MON 95275 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council

COMCMT1R-EP1R-C2R-EPCNCADO

Updated 18mo ago

This resolution expresses the European Parliament's objection to authorising genetically modified maize MON 95275 for use in food and animal feed within the EU.

The objection affects companies seeking to market products derived from this specific genetically modified maize, as well as consumers and farmers who would potentially use these products.

The Parliament argues that the draft authorisation exceeds the Commission's powers and is inconsistent with EU law's aim to ensure a high level of protection for human health, animal welfare, and the environment.

Concerns include insufficient data on unintended genetic effects, potential impacts on non-target organisms, gene flow risks, and inadequate monitoring requirements, echoing previous objections to GMO authorisations.

Documents

Regulation on the market of products containing, consisting of or produced from genetically modified maize MON 95275 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council

position · EN · 2026-04-01

↗

Analysis

AI-generated·5 Apr 2026·Source document·Unverified

An application was submitted for placing on the market of foods, food ingredients, and feed containing or produced from genetically modified maize MON 95275.

What changes

The European Parliament calls on the Commission to withdraw its draft implementing decision for authorising genetically modified maize MON 95275.
The Parliament requests the Commission to submit a new draft implementing decision to the committee.
The Commission is called upon not to authorise the GM crops due to risks to biodiversity, food safety, and workers’ health.

Expected impact

The draft Commission implementing decision is considered not consistent with Union law and exceeds implementing powers provided for in Regulation (EC) No 1829/2003.
Concerns are raised about the potential for gene flow to wild relatives, leading to transgene persistence and ecological imbalance.
The use of insecticidal GM crops leads to continuous exposure of organisms to toxins, unlike the limited exposure from spraying insecticides.

Limitations

The document is a resolution of the European Parliament and does not contain the full Commission implementing decision or the EFSA scientific opinion, limiting the ability to analyze the specific technical details of the authorisation process.
The document does not provide specific details on the economic impact of authorising or not authorising the GM maize MON 95275.

Learn more

How EU laws are made Reading voting records What is a trilogue?